Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resection
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s10147-021-02111-7.pdf
Reference38 articles.
1. Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
2. Yang HJ, Guo Z, Yang YT et al (2016) Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol 22:5088–5095
3. Yoshida H, Shiratori Y, Moriyama M et al (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with Chronic Hepatitis C in Japan. IHIT study group. inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med 131:174–181
4. Ko S, Kanehiro H, Hisanaga M et al (2002) Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89:57–62
5. Gassmann P, Spieker T, Haier J et al (2010) Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg 34:2442–2451
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protein induced by vitamin K absence or antagonist II: Experience to date and future directions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11
2. Liver injury indicators and subsequent cancer development among non‐fatty liver population;Cancer Medicine;2023-04-04
3. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients;Journal of Circulating Biomarkers;2023-02-17
4. Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort;Journal of Oncology;2022-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3